UK markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.70-0.23 (-0.89%)
At close: 04:00PM EDT
25.70 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.12B
Enterprise value 1.10B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.30
Price/book (mrq)2.16
Enterprise value/revenue 2.91
Enterprise value/EBITDA -7.03

Trading information

Stock price history

Beta (5Y monthly) 1.77
52-week change 3-18.59%
S&P500 52-week change 323.42%
52-week high 349.50
52-week low 316.95
50-day moving average 333.01
200-day moving average 327.70

Share statistics

Avg vol (3-month) 31.43M
Avg vol (10-day) 31.38M
Shares outstanding 581.66M
Implied shares outstanding 681.66M
Float 873.33M
% held by insiders 11.84%
% held by institutions 189.57%
Shares short (28 Mar 2024) 413.45M
Short ratio (28 Mar 2024) 410.67
Short % of float (28 Mar 2024) 420.88%
Short % of shares outstanding (28 Mar 2024) 416.47%
Shares short (prior month 29 Feb 2024) 413.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -35.09%
Operating margin (ttm)42.02%

Management effectiveness

Return on assets (ttm)-7.87%
Return on equity (ttm)-15.46%

Income statement

Revenue (ttm)377.71M
Revenue per share (ttm)4.90
Quarterly revenue growth (yoy)1,478.00%
Gross profit (ttm)N/A
EBITDA -156.47M
Net income avi to common (ttm)-132.53M
Diluted EPS (ttm)-1.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.19B
Total cash per share (mrq)15.11
Total debt (mrq)173.17M
Total debt/equity (mrq)17.65%
Current ratio (mrq)5.89
Book value per share (mrq)12.47

Cash flow statement

Operating cash flow (ttm)-149.2M
Levered free cash flow (ttm)-50.84M